Karikó, Katalin http://orcid.org/0000-0002-1864-3851
Article History
First Online: 27 September 2021
Competing interests
: K.K. is named on patents that describe the use of nucleoside-modified mRNA as a platform to deliver therapeutic proteins. She is employee of BioNTech SE, a company that develops mRNA-based therapies.
Free to read: This content has been made available to all.